Robot-Assisted Endoscopes Market: Rising Demand for Minimally Invasive Surgeries to Drive Market Growth to US$ 515.53 Million by 2031

As per the latest market research by Business Market Insights (BMI), the research report "Robot-Assisted Endoscopes Market Size and Forecast (2025–2031)" forecasts how the market is set to surge 75.98% by 2031. The robot-assisted endoscopes market is advancing with innovations in robotic precision, AI-guided navigation, and enhanced 3D imaging. Rising demand for minimally invasive procedures, increasing gastrointestinal and urological disease burden, and aging populations are key drivers. Expanding outpatient care and healthcare investments in emerging economies further accelerate global adoption and accessibility.

The report forecasts the market to expand from US$ 292.94 million in 2024 to US$ 515.53 million by 2031, registering a robust CAGR of 8.41% over the 2025–2031 period.

The robot-assisted endoscopes market is seeing robust growth driven by advances in technology, increasing demand for minimally invasive procedures, and the rising prevalence of gastrointestinal, urological, and respiratory disorders. These systems offer enhanced precision, 3D visualization, and improved ergonomics, thus being increasingly preferred in complex diagnostic and therapeutic procedures. The trend toward aging populations and a shift globally toward outpatient and ambulatory care further fuels adoption. Manufacturers are investing in AI integration, compact system design, and cloud connectivity to meet evolving clinical needs and expand into emerging markets. Despite the high initial costs and regulatory hurdles, the market is bound to see further expansion with strategic collaborations, subscription-based models, and an increase in acceptance of robotic platforms in both developed and developing healthcare infrastructures.

Overview of report findings

Market Growth

The robot-assisted endoscopes market is projected to grow from US$ 292.94 million in 2024 to US$ 515.53 million by 2031, registering a compound annual growth rate (CAGR) of 8.41% between 2025 and 2031.

The robot-assisted endoscopes market is advancing with innovations in robotic precision, AI-guided navigation, and enhanced 3D imaging. Rising demand for minimally invasive procedures, increasing gastrointestinal and urological disease burden, and aging populations are key drivers. Expanding outpatient care and healthcare investments in emerging economies further accelerate global adoption and accessibility.

Rising Demand for Minimally Invasive Surgeries

Minimally invasive surgeries are increasingly preferred due to their reduced trauma, faster recovery, and lower risk of complications compared to traditional open procedures. Robot-assisted endoscopes can improve minimally invasive surgeries, particularly in anatomically complicated spaces, by providing greater precision, technique, and visualization. Robot-assisted endoscopes may allow surgeons to perform a range of minimally invasive surgeries through smaller incisions, and thus limit pain and length of hospitalization. In addition, hospitals continue to transition to outpatient care and patient-centered treatment models, which allows minimally invasive surgery to expand readily. Advancements in robotic technology, from AI-assisted surgeon navigation to 3D imaging, will significantly widen the application of minimally invasive surgery across numerous specialties such as gastroenterology, pulmonology, and urology. As healthcare facilities become more efficient, and outcomes become a greater focus, the demand for robot-assisted minimally invasive procedures will continue to increase, further enhancing market growth.

Growing Prevalence of GI, and Pulmonary Disorders

The​‍​‌‍​‍‌​‍​‌‍​‍‌ robot-assisted endoscopes market is largely influenced by the rising incidence of gastrointestinal (GI) and pulmonary disorders. Gastrointestinal diseases such as colorectal cancer, inflammatory bowel disease, GERD, and chronic obstructive pulmonary disease (COPD) necessitate the accurate diagnosis and the targeted treatment which is followed by endoscopic interventions frequently. Robot-assisted systems offer enhanced visualization, and precision, enabling early detection and minimally invasive interventions. The global rise in disease burden is due to the aging populations, lifestyle changes, and environmental factors. Besides, the requirement for easily repeatable, high-quality diagnostics in highly complicated situations is leading hospitals to invest in robotic platforms. As a result of increased awareness and screening programs, the demand for advanced endoscopic instruments, particularly those which have the potential to improve the treatment and lower the risks, is getting higher and higher in the different healthcare ​‍​‌‍​‍‌​‍​‌‍​‍‌systems.

Geographic Insights

North America dominates the market due to the presence of well-established healthcare infrastructures, as well as, a higher proportion of adoption of robotic technologies and prominent manufacturers of robotic surgical devices. Additionally, favorable reimbursement policies and an increase in demand for minimally invasive procedures will further drive the region.

Europe is the second-largest market, and is expanding as the geriatric population increases, the prevalence of gastrointestinal disorders is on the rise, and robot surgery programs are expanding. Government initiatives for radical inventions targeting new technology for health and accelerating healthcare digitisation also support the uptake of robotic surgery systems in regions such as Germany, France, and the UK.

 Asia Pacific is expected to exhibit the highest growth during the forecast period due to rising healthcare investment, growing awareness of robotic procedures, and increase disease burden. Emerging economies, such as China, India and South Korea, are adopting robotic endoscopy systems to modernize existing surgical capabilities to promote better patient outcomes.

Market Segmentation

• By product type, the robot-assisted endoscope market is segmented into therapeutic and diagnostic. The therapeutic segment dominated the market in 2024.
• By application, the robot-assisted endoscope market is segmented into gastrointestinal endoscopy, laparoscopy, bronchoscopy, and others. The gastrointestinal endoscopy segment dominated the market in 2024.
• By end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers and others. The hospitals segment held the largest share of the market in 2024.

Competitive Strategy & Development

Key Players: The Robot-Assisted Endoscopes market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Intuitive Surgical Operations, Inc.
2. Johnson & Johnson
3. Medtronic
4. MicroPort Scientific Corporation
5. Stryker Corporation
6. Brainlab SE
7. Meril
8. Moon Surgical
9. KARL STORZ

Trending Topics: Capsule Endoscope, Reusable Endoscopes, Rigid Endoscope, Single-Use Endoscopes, Flexible Endoscope, Ultrasound Endoscopes.

Global Headlines

• Intuitive announced approval of Da Vinci 5 – In March 2024, Intuitive announced that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for Da Vinci 5, the company’s next-generation multiport robotic system.
• CMR Surgical announced approval of Da Vinci – In October 2024, CMR Surgical announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Versius Surgical System (Versius), paving the way for a next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.

Conclusion

The robot-assisted endoscopes market is poised for sustained growth, driven by technological innovation, rising disease burden, and demand for minimally invasive care. With expanding global healthcare infrastructure and evolving clinical needs, manufacturers have strong opportunities to innovate, collaborate, and deliver precision-driven solutions that redefine diagnostic and therapeutic endoscopy worldwide.